Topics

J&J reach $20.4m settlement agreement over opioid trial

08:30 EDT 2 Oct 2019 | European Pharmaceutical Review

Johnson & Johnson have reached a settlement with two Ohio counties over its role in the opioid crisis, removing the company from the trial due to begin later this month.

The post J&J reach $20.4m settlement agreement over opioid trial appeared first on European Pharmaceutical Review.

Original Article: J&J reach $20.4m settlement agreement over opioid trial

NEXT ARTICLE

More From BioPortfolio on "J&J reach $20.4m settlement agreement over opioid trial"

Quick Search

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...